Clinical Trial Search

Primary: Number of Participants With Niche Visualized by Saline Infusion Sonography — 40; 53; 25; 23 Participants — p=0.05

Primary: Rates of Uterine Perforation — 0 Number of cases

Primary: Number of Participants With Absence of Newly Formed Intrauterine Adhesions Following RF Ablation of Fibroids — 34 Participants

Primary: Number of Participants Completing Natural Orifice Translumenal Endoscopic Surgical (NOTES) Repair — 2; 1 participants

Primary: Placenta Previa — 18; 17; 0; 3 Participants

Primary: The Ease of IUD Insertion as Rated by the Provider Using a 100mm Visual Analog Scale (VAS). — 24; 29 mm

Primary: Safety (Adverse Events) — 0 device related adverse event

Primary: Patient Perceived Pain on a 100-point Visual Analogue Scale. — 0.5; 0.8; 5.8; 5.9 units on a scale

Primary: Proportion of Subjects Reporting AEs of Chronic Lower Abdominal and/or Pelvic Pain After Insertion of Essure System or After Laparoscopic Tubal Sterilization — 39; 28…

Primary: Patient-perceived Pain — 3; 4 score on a scale — p=0.21

Primary: Chemical Pregnancy Rate — 40; 19 participants

Primary: Provider Perceived Ease of Insertion on a 100 Point Visual Analogue Scale — 21; 21 units on a scale

Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants

Primary: Cesarean Scar Defect in the Uterine Incisional Line — 12; 39 participants — p=0.0001

Primary: Surgical Glove Perforation. — 30; 30 Cases with a glove puncture

Primary: Number of Participants With Adhesion Reformation (American Fertility Society Score of Greater Than 0) 8 Weeks Later After the Index Surgery — 21; 38 Participants — p=0.012

Primary: Provider Perceived Ease of Insertion on a 100-point Visual Analogue Scale (VAS) — 25.1; 27.4 units on a scale — p=0.64

Primary: Number of Adverse Events — 1 Participants

Primary: Successful Retention of IUD — 7 participants

Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05

Primary: Intrauterine Fluid Volume Lost — 2.2; 7.8 ml

Primary: To Determine if the LigaSure Device, Which we Routinely Used for Removal of Tubes and Ovaries, is Effective at Destroying All Tubal Cells Comprising the Fallopian Tube…

Primary: Hemoglobin Levels Difference Between Pre and Post Surgery. — 0.76; 0.93 g/dL

Primary: Surgical Blood Loss — 761; 691 ml

Primary: Blood Loss — 616; 418; 141; 106 cc

Primary: Number of Participants With Pregnancy in Loop-shaped Intrauterine Device Group and Intrauterine Balloon Group — 12; 22 participants — p=0.009

Primary: Cumulative Failure — 78; 69; 9; 16 Participants

Primary: Percentage of Subjects With ≥ 50% Reduction in Menstrual Blood Loss as Assessed by Pictorial Blood Loss Assessment Chart (PBAC) — 64.8 percentage of participants

Primary: Percentage of Tissue Removed — 97.5 Percentage of tissue removed

Primary: Uterine Perforation Rate — 61; 20 participants